Selected research
Industry Growth & Trends
Global Neurocognitive Assessment and Rehabilitation Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Neurocognitive Assessment and Rehabilitation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Neurocognitive Assessment and Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Neurocognitive Assessment and Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Neurocognitive Assessment and Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Neurocognitive Assessment and Rehabilitation market include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health and NeuronUP SL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Neurocognitive Assessment and Rehabilitation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Neurocognitive Assessment and Rehabilitation market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neurocognitive Assessment and Rehabilitation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neurocognitive Assessment and Rehabilitation.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Neurocognitive Assessment and Rehabilitation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Neurocognitive Assessment and Rehabilitation Market by Company
Cambridge Cognition Holdings plc
Cognifit, Inc.
Cogstate Ltd.
Lumos Labs, Inc. (Lumosity)
CNS Vital Signs, LLC
Posit Science Corporation
BrainCheck, Inc.
Constant Therapy Health
NeuronUP SL
SCHUHFRIED GmbH
Neurocognitive Assessment and Rehabilitation Segment by Type
Neurorehabilitation Therapy
Neurocognitive Assessment Testing
Neurocognitive Assessment and Rehabilitation Segment by Application
Rehab Centers
Hospital & Clinics
Homecare Settings
Physiotherapy Centers
Neurocognitive Assessment and Rehabilitation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurocognitive Assessment and Rehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurocognitive Assessment and Rehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurocognitive Assessment and Rehabilitation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Neurocognitive Assessment and Rehabilitation companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Neurorehabilitation Therapy
- Neurocognitive Assessment Testing
Applications
- Rehab Centers
- Hospital & Clinics
- Homecare Settings
- Physiotherapy Centers
Companies covered
- Cambridge Cognition Holdings plc
- Cognifit, Inc.
- Cogstate Ltd.
- Lumos Labs, Inc. (Lumosity)
- CNS Vital Signs, LLC
- Posit Science Corporation
- BrainCheck, Inc.
- Constant Therapy Health
- NeuronUP SL
- SCHUHFRIED GmbH
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Neurocognitive Assessment and Rehabilitation Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Neurocognitive Assessment and Rehabilitation Market Size by Region (2021-2032)
- 1.4.1 Global Neurocognitive Assessment and Rehabilitation Market Size by Region (2021-2026)
- 1.4.2 Global Neurocognitive Assessment and Rehabilitation Market Size by Region (2027-2032)
- 1.5 Key Regions Neurocognitive Assessment and Rehabilitation Market Size (2021-2032)
- 1.5.1 North America Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (2021-2032)
- 1.5.4 South America Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (2021-2032)
2 Neurocognitive Assessment and Rehabilitation Market by Type
- 2.1 Type Introduction
- 2.1.1 Neurorehabilitation Therapy
- 2.1.2 Neurocognitive Assessment Testing
- 2.2 Global Neurocognitive Assessment and Rehabilitation Market Size by Type
- 2.2.1 Global Neurocognitive Assessment and Rehabilitation Market Size Overview by Type (2021-2032)
- 2.2.2 Global Neurocognitive Assessment and Rehabilitation Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Neurocognitive Assessment and Rehabilitation Market Size Forecasted by Type (2027-2032)
- 2.3 Global Neurocognitive Assessment and Rehabilitation Market Size by Regions
- 2.3.1 North America Neurocognitive Assessment and Rehabilitation Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Neurocognitive Assessment and Rehabilitation Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Neurocognitive Assessment and Rehabilitation Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Neurocognitive Assessment and Rehabilitation Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Size Breakdown by Type (2021-2026)
3 Neurocognitive Assessment and Rehabilitation Market by Application
- 3.1 Type Introduction
- 3.1.1 Rehab Centers
- 3.1.2 Hospital & Clinics
- 3.1.3 Homecare Settings
- 3.1.4 Physiotherapy Centers
- 3.2 Global Neurocognitive Assessment and Rehabilitation Market Size by Application
- 3.2.1 Global Neurocognitive Assessment and Rehabilitation Market Size Overview by Application (2021-2032)
- 3.2.2 Global Neurocognitive Assessment and Rehabilitation Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Neurocognitive Assessment and Rehabilitation Market Size Forecasted by Application (2027-2032)
- 3.3 Global Neurocognitive Assessment and Rehabilitation Market Size by Regions
- 3.3.1 North America Neurocognitive Assessment and Rehabilitation Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Neurocognitive Assessment and Rehabilitation Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Neurocognitive Assessment and Rehabilitation Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Neurocognitive Assessment and Rehabilitation Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Neurocognitive Assessment and Rehabilitation Industry Trends
- 4.2 Neurocognitive Assessment and Rehabilitation Industry Drivers
- 4.3 Neurocognitive Assessment and Rehabilitation Industry Opportunities and Challenges
- 4.4 Neurocognitive Assessment and Rehabilitation Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Neurocognitive Assessment and Rehabilitation Revenue (2021-2026)
- 5.2 Global Neurocognitive Assessment and Rehabilitation Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Neurocognitive Assessment and Rehabilitation Key Company Headquarters & Area Served
- 5.4 Global Neurocognitive Assessment and Rehabilitation Company, Product Type & Application
- 5.5 Global Neurocognitive Assessment and Rehabilitation Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Neurocognitive Assessment and Rehabilitation Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Neurocognitive Assessment and Rehabilitation Players Market Share by Revenue in 2025
- 5.6.3 2025 Neurocognitive Assessment and Rehabilitation Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Cambridge Cognition Holdings plc
- 6.1.1 Cambridge Cognition Holdings plc Company Information
- 6.1.2 Cambridge Cognition Holdings plc Business Overview
- 6.1.3 Cambridge Cognition Holdings plc Neurocognitive Assessment and Rehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Cambridge Cognition Holdings plc Neurocognitive Assessment and Rehabilitation Product Portfolio
- 6.1.5 Cambridge Cognition Holdings plc Recent Developments
- 6.2 Cognifit, Inc.
- 6.2.1 Cognifit, Inc. Company Information
- 6.2.2 Cognifit, Inc. Business Overview
- 6.2.3 Cognifit, Inc. Neurocognitive Assessment and Rehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Cognifit, Inc. Neurocognitive Assessment and Rehabilitation Product Portfolio
- 6.2.5 Cognifit, Inc. Recent Developments
- 6.3 Cogstate Ltd.
- 6.3.1 Cogstate Ltd. Company Information
- 6.3.2 Cogstate Ltd. Business Overview
- 6.3.3 Cogstate Ltd. Neurocognitive Assessment and Rehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Cogstate Ltd. Neurocognitive Assessment and Rehabilitation Product Portfolio
- 6.3.5 Cogstate Ltd. Recent Developments
- 6.4 Lumos Labs, Inc. (Lumosity)
- 6.4.1 Lumos Labs, Inc. (Lumosity) Company Information
- 6.4.2 Lumos Labs, Inc. (Lumosity) Business Overview
- 6.4.3 Lumos Labs, Inc. (Lumosity) Neurocognitive Assessment and Rehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Lumos Labs, Inc. (Lumosity) Neurocognitive Assessment and Rehabilitation Product Portfolio
- 6.4.5 Lumos Labs, Inc. (Lumosity) Recent Developments
- 6.5 CNS Vital Signs, LLC
- 6.5.1 CNS Vital Signs, LLC Company Information
- 6.5.2 CNS Vital Signs, LLC Business Overview
- 6.5.3 CNS Vital Signs, LLC Neurocognitive Assessment and Rehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 CNS Vital Signs, LLC Neurocognitive Assessment and Rehabilitation Product Portfolio
- 6.5.5 CNS Vital Signs, LLC Recent Developments
- 6.6 Posit Science Corporation
- 6.6.1 Posit Science Corporation Company Information
- 6.6.2 Posit Science Corporation Business Overview
- 6.6.3 Posit Science Corporation Neurocognitive Assessment and Rehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Posit Science Corporation Neurocognitive Assessment and Rehabilitation Product Portfolio
- 6.6.5 Posit Science Corporation Recent Developments
- 6.7 BrainCheck, Inc.
- 6.7.1 BrainCheck, Inc. Company Information
- 6.7.2 BrainCheck, Inc. Business Overview
- 6.7.3 BrainCheck, Inc. Neurocognitive Assessment and Rehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 BrainCheck, Inc. Neurocognitive Assessment and Rehabilitation Product Portfolio
- 6.7.5 BrainCheck, Inc. Recent Developments
- 6.8 Constant Therapy Health
- 6.8.1 Constant Therapy Health Company Information
- 6.8.2 Constant Therapy Health Business Overview
- 6.8.3 Constant Therapy Health Neurocognitive Assessment and Rehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Constant Therapy Health Neurocognitive Assessment and Rehabilitation Product Portfolio
- 6.8.5 Constant Therapy Health Recent Developments
- 6.9 NeuronUP SL
- 6.9.1 NeuronUP SL Company Information
- 6.9.2 NeuronUP SL Business Overview
- 6.9.3 NeuronUP SL Neurocognitive Assessment and Rehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 NeuronUP SL Neurocognitive Assessment and Rehabilitation Product Portfolio
- 6.9.5 NeuronUP SL Recent Developments
- 6.10 SCHUHFRIED GmbH
- 6.10.1 SCHUHFRIED GmbH Company Information
- 6.10.2 SCHUHFRIED GmbH Business Overview
- 6.10.3 SCHUHFRIED GmbH Neurocognitive Assessment and Rehabilitation Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 SCHUHFRIED GmbH Neurocognitive Assessment and Rehabilitation Product Portfolio
- 6.10.5 SCHUHFRIED GmbH Recent Developments
7 North America
- 7.1 North America Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Neurocognitive Assessment and Rehabilitation Market Size by Country (2021-2026)
- 7.3 North America Neurocognitive Assessment and Rehabilitation Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Neurocognitive Assessment and Rehabilitation Market Size by Country (2021-2026)
- 8.3 Europe Neurocognitive Assessment and Rehabilitation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Neurocognitive Assessment and Rehabilitation Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Neurocognitive Assessment and Rehabilitation Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Neurocognitive Assessment and Rehabilitation Market Size by Country (2021-2026)
- 10.3 South America Neurocognitive Assessment and Rehabilitation Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Neurocognitive Assessment and Rehabilitation Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Neurocognitive Assessment and Rehabilitation Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst